Annals of Colorectal Research

Published by: Kowsar

Gradual Histopathologic Changes During Development of Colorectal Cancer

Vahid Nejati 1 , Jamileh Abedi 1 , Maedeh Vakili Saatloo 2 , * , Maryam Koohsoltani 3 , Rahim Hobbenaghi 4 and Amir Tukmachi 5
Authors Information
1 Department of Biology, Faculty of Sciences, Urmia University, Urmia, Iran
2 Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Urmia University of Medical Sciences, Urmia, Iran
3 Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran
4 Department of Pathology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran
5 Department of Pathobiology and Quality Control, Artemia and Aquatic Animals Research Institute, Urmia University, Urmia, Iran
Article information
  • Annals of Colorectal Research: March 31, 2019, 7 (1); e87080
  • Published Online: March 28, 2019
  • Article Type: Research Article
  • Received: December 4, 2018
  • Revised: March 16, 2019
  • Accepted: March 18, 2019
  • DOI: 10.5812/acr.87080

To Cite: Nejati V, Abedi J, Vakili Saatloo M, Koohsoltani M, Hobbenaghi R, et al. Gradual Histopathologic Changes During Development of Colorectal Cancer, Ann Colorectal Res. 2019 ; 7(1):e87080. doi: 10.5812/acr.87080.

Copyright © 2019, Annals of Colorectal Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Cappell MS. Pathophysiology, clinical presentation, and management of colon cancer. Gastroenterol Clin North Am. 2008;37(1):1-24. v. doi: 10.1016/j.gtc.2007.12.002. [PubMed: 18313537].
  • 2. Bird RP. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett. 1995;93(1):55-71. doi: 10.1016/0304-3835(95)03788-X. [PubMed: 7600544].
  • 3. Hussain SP, Amstad P, Raja K, Ambs S, Nagashima M, Bennett WP, et al. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: A cancer-prone chronic inflammatory disease. Cancer Res. 2000;60(13):3333-7. [PubMed: 10910033].
  • 4. Muller PA, Vousden KH. Mutant p53 in cancer: New functions and therapeutic opportunities. Cancer Cell. 2014;25(3):304-17. doi: 10.1016/j.ccr.2014.01.021. [PubMed: 24651012]. [PubMed Central: PMC3970583].
  • 5. Thomadaki H, Scorilas A. BCL2 family of apoptosis-related genes: Functions and clinical implications in cancer. Crit Rev Clin Lab Sci. 2006;43(1):1-67. doi: 10.1080/10408360500295626. [PubMed: 16531274].
  • 6. Zinkel S, Gross A, Yang E. BCL2 family in DNA damage and cell cycle control. Cell Death Differ. 2006;13(8):1351-9. doi: 10.1038/sj.cdd.4401987. [PubMed: 16763616].
  • 7. Pretlow TP, Pretlow TG. Mutant KRAS in aberrant crypt foci (ACF): Initiation of colorectal cancer? Biochim Biophys Acta. 2005;1756(2):83-96. doi: 10.1016/j.bbcan.2005.06.002. [PubMed: 16219426].
  • 8. Ochiai M, Ushigome M, Fujiwara K, Ubagai T, Kawamori T, Sugimura T, et al. Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Am J Pathol. 2003;163(4):1607-14. doi: 10.1016/S0002-9440(10)63517-1. [PubMed: 14507667]. [PubMed Central: PMC1868301].
  • 9. Magnuson BA, Shirtliff N, Bird RP. Resistance of aberrant crypt foci to apoptosis induced by azoxymethane in rats chronically fed cholic acid. Carcinogenesis. 1994;15(7):1459-62. doi: 10.1093/carcin/15.7.1459. [PubMed: 8033325].
  • 10. Bossi P, Viale G, Lee AK, Alfano R, Coggi G, Bosari S. Angiogenesis in colorectal tumors: Microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res. 1995;55(21):5049-53. [PubMed: 7585550].
  • 11. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436-44. doi: 10.1038/nature07205. [PubMed: 18650914].
  • 12. Jass JR, Love SB, Northover JM. A new prognostic classification of rectal cancer. Lancet. 1987;1(8545):1303-6. doi: 10.1016/S0140-6736(87)90552-6. [PubMed: 2884421].
  • 13. Ohtani H. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. Cancer Immun. 2007;7:4. [PubMed: 17311363]. [PubMed Central: PMC2935759].
  • 14. Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma VM. Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol. 1997;182(3):318-24. doi: 10.1002/(SICI)1096-9896(199707)182:3<318::AID-PATH862>3.0.CO;2-6. [PubMed: 9349235].
  • 15. Maseko T, Howell K, Dunshea FR, Ng K. Selenium-enriched Agaricus bisporus increases expression and activity of glutathione peroxidase-1 and expression of glutathione peroxidase-2 in rat colon. Food Chem. 2014;146:327-33. doi: 10.1016/j.foodchem.2013.09.074. [PubMed: 24176350].
  • 16. Finley JW, Davis CD, Feng Y. Selenium from high selenium broccoli protects rats from colon cancer. J Nutr. 2000;130(9):2384-9. doi: 10.1093/jn/130.9.2384. [PubMed: 10958840].
  • 17. Akagi K, Ikeda Y, Sumiyoshi Y, Kimura Y, Kinoshita J, Miyazaki M, et al. Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development. Surgery. 2002;131(1 Suppl):S109-13. doi: 10.1067/msy.2002.119361. [PubMed: 11821796].
  • 18. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings. Cancer Lett. 1987;37(2):147-51. doi: 10.1016/0304-3835(87)90157-1. [PubMed: 3677050].
  • 19. Xiao H, Hao X, Simi B, Ju J, Jiang H, Reddy BS, et al. Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats. Carcinogenesis. 2008;29(1):113-9. doi: 10.1093/carcin/bgm204. [PubMed: 17893236].
  • 20. Ward JM. Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats. Lab Invest. 1974;30(4):505-13. [PubMed: 4363166].
  • 21. Davis CD, Uthus EO. Dietary folate and selenium affect dimethylhydrazine-induced aberrant crypt formation, global DNA methylation and one-carbon metabolism in rats. J Nutr. 2003;133(9):2907-14. doi: 10.1093/jn/133.9.2907. [PubMed: 12949386].
  • 22. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med. 1991;324(1):1-8. doi: 10.1056/NEJM199101033240101. [PubMed: 1701519].
  • 23. Saad RS, Kordunsky L, Liu YL, Denning KL, Kandil HA, Silverman JF. Lymphatic microvessel density as prognostic marker in colorectal cancer. Mod Pathol. 2006;19(10):1317-23. doi: 10.1038/modpathol.3800651. [PubMed: 16799477].
  • 24. Des Guetz G, Uzzan B, Nicolas P, Cucherat M, Morere JF, Benamouzig R, et al. Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br J Cancer. 2006;94(12):1823-32. doi: 10.1038/sj.bjc.6603176. [PubMed: 16773076]. [PubMed Central: PMC2361355].
  • 25. Bosari S, Viale G, Bossi P, Maggioni M, Coggi G, Murray JJ, et al. Cytoplasmic accumulation of p53 protein: An independent prognostic indicator in colorectal adenocarcinomas. J Natl Cancer Inst. 1994;86(9):681-7. doi: 10.1093/jnci/86.9.681. [PubMed: 8158699].
  • 26. Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM, et al. Inhibition of apoptosis during development of colorectal cancer. Cancer Res. 1995;55(9):1811-6. [PubMed: 7728743].
  • 27. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005;91(3):181-4. doi: 10.1002/jso.20329. [PubMed: 16118772].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments